Sacituzumab govitecan User Reviews & Ratings
Brand names: Trodelvy
Sacituzumab govitecan has an average rating of 7.4 out of 10 from a total of 5 reviews on Drugs.com. 80% of reviewers reported a positive experience, while 20% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Breast Cancer | 5 reviews for Breast Cancer | 82 medications |
- Jan...
- Taken for 1 to 6 months
- January 19, 2024
Sacituzumab govitecan for Breast Cancer "I occasionally have slurred speech and difficulty swallowing. It's kind of intermittent. No other side effect except complete alopecia"
- Ell...
- February 5, 2024
Sacituzumab govitecan for Breast Cancer "Other than neutropenia and alopecia, my side effects are minimal. I'm in the middle of my treatment plan, still hopeful that this will give me a sustained remission."
See also:
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Herceptin
Herceptin is used to treat patients with metastatic breast cancer. Learn about side effects ...
Ibrance
Ibrance is used to treat HR-positive, HER2-negative breast cancer in postmenopausal women or men ...
- sil...
- Taken for 6 months to 1 year
- December 5, 2024
Sacituzumab govitecan for Breast Cancer "It helped to have good PET scans and to shrink tumors in my chest."
- Sta...
- Taken for 1 to 6 months
- April 24, 2024
Sacituzumab govitecan for Breast Cancer "Horrible paralyzing bone pain. Horrible constipation or diarrhea. Horrible experience. Also, face numbness."
Are you taking this medicine?
Your review helps others make informed decisions.More about sacituzumab govitecan
- Check interactions
- Compare alternatives
- Reviews (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
For Breast Cancer "Excellent response in my daughter’s breathing. She has stage 4 inflammatory breast cancer that has spread to her lungs. After just 24 hours of taking this chemotherapy, she is breathing without difficulty."